Xellia Pharmaceuticals Expands US Production with Acquisition of Manufacturing Plant from Hikma Pharmaceuticals

SourceBusiness Wire
Date Published11/25/2015
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Xellia Pharmaceuticals
Type of work Manufacturing
Reshoring category:Transplant
Year reshoring announced:2015
Country(ies) from which reshored:Denmark
City reshored to:Bedford
State(s) reshored to:OH
If relevant, work nearshored to:-
Product(s) reshoredAnti-Infective Pharmaceuticals
What domestic positive factors made reshoring more attractive?Proximity to customers/market
Find Reshoring Articles